Abstract
United States statistics continue to indicate that the human donor heart pool does not and will not meet the great demand for hearts. For those patients unresponsive to maximal medical therapy (approximately 60,000 patients per year), cardiac transplantation is currently their best hope for increased survival. To address the need for additional end-stage congestive heart failure (CHF) therapy options, three medical device manufacturers have developed implantable left ventricular assist devices (LVAD) which act as a pump for hemodynamic support of the patient’s diseased heart. Although LVADs have been shown to improve patient disease state prior to organ transplantation. LVADs do nothing to increase the pool of human donor hearts, and they negatively impact the United Network for Organ Sharing (UNOS) waiting list by increasing the size of the waiting pool. This paper identifies and explores the ethical challenges presented by the use of LVADs as a bridging technology for heart transplant candidates. Although LVADs raise some ethical concerns, these concerns are outweighed by the proven medical efficacy of these devices. Thus, this technology should continue to be used and further developed.
Similar content being viewed by others
References
Tyagi S. C. (1998) Extracellular matrix dynamics in heart failure: a prospect for gene therapy. Journal of Cell Biochemistry 68: 403–410.
Simons W. R., Haim M., Rizzo J., Zannad F. (1996) Effect of improved disease management strategies on hospital length of stay in the treatment of congestive heart failure. Clinical Therapeutics 18: 726–746.
Kriett J M & Kaye M P (1991) The registry of the international society for heart and lung transplantation. Journal of Heart and Lung Transplantation 10: 491–498.
First Alternative Implant of Mechanical Heart Pump at CMPC. Doctor’s Guide to Medical and Other News, P∖S∖L consulting Group Inc., April 12, 1996.
Ctanese K A, Goldstein D J, Williams D L, Foray A T, Illick C D, Gardocki M T, Wenberg A D, Levin H R, Rose E A & Oz M C (1996) Outpatient left ventricular assist device support: a destination rather than a bridge. Annals of Thoracic Surgery 62: 646–653.
Dipla K., Mattiello, J.A., Jeevanandam, V., Houser, S.R. & Margulies, K.B. (1998) Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure. Circulation 97:2316–2322.
Maugh, T.H. (16 June 1998) "Heart Assist Pumps Found to Revive Cells.” Los Angeles Times:A1.
Frazier, O.H., Rose, E.A., McCarthy, P., Burton, N.A., Tector, A., Levin, H., Kayne, H.L., Porirer, V.L. & Dasse, K.A. (1995) Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system. Annals of Surgery 222: 327–338.
Burnett, C.M., Duncan, J.M., Frazier, O.H., Sweeney, M.S., Vega, J.D. & Radovancevie, B. (1993) Improved multiorgan function after prolonged univentricular support. Annals of Thoracic Surgery 55: 65–71.
Levin, H.L., Chen, J.M., Dasse, K.A. & Graham, T.R. (1995) End-organ function during mechanical left ventricular assistance, In: Lewis, T. & Graham, T.R., eds., Mechanical circulatory support. Edward Arnold Press, Boston: 179–185.
Dew, M.A., Kormos, R.L., Roth, L.H., Armitage, J.M., Pristas, J.M., Harris, R.C., Capretta, C. & Griffith, B.P. (1993) Life quality in the era of bridging to cardiac transplantation bridge patients in an outpatient setting. American Association for Artificial Internal Organs Journal 39: 145–152.
Levin, H.R., Chen, J.M., Oz, M.C., Catanese, K.A., Krum, H., Goldsmith, R.L., Packer, M. & Rose, E.A. (1994) Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation. Annals of Thoracic Surgery 58: 1515–1520.
Burton, N.A., Lefrak, E.A., Macmanus, Q., Hill, A., Marino, J.A., Spier, A.M., Akl, B.F. & Arbus, R.A. (1993) A reliable bridge to cardiac transplantation: the TCI left ventricular assist device. Annals of Thoracic Surgery 55: 1425–1431.
Blue Cross and Blue Shield Association (1997) Ventricular assist devices in bridging to heart transplantation. Blue Cross Blue Shield Technology Evaluation Center Assessment Program 11: 1–26.
Farrar, J.D. & Hill, J.D. (1993) Univentricular and biventricular Thoratec VAD support as a bridge to transplantation. Annals of Thoracic Surgery 55: 276–282.
Pennington, D.G., McBride, L.R., Miller, L.W., Peigh, P.S. & Swartz, M.T. (1994) Eight years’ experience with bridging to cardiac transplantation. Journal of Thoracic and Cardiovascular Surgery 107: 472–481.
Herrmann, M., Weyand, M., Greshake, B., von Eiff, C., Proctor, R.A., Scheld, H.H. & Peters, G. (1997) Left ventricular assist device infection is associated with increased mortality but is not a contraindication to heart transplantation. Circulation 95: 814–817.
Massad, M.G., McCarthy, P.M., Smedira, N.G., Cook, D.J., Ratliff, N.B., Goormastic, M., Vargo, R.L., Navia, J., Young, J.B. & Stewart, R.W. (1996) Does successful bridging with the implantable left ventricular assist device affect cardiac transplantation outcome? Journal of Thoracic and Cardiovascular Surgery 112: 1275–83.
Institute of Medicine (1991) The artificial heart: prototypes, policies and patients. National Academy Press, Washington DC: 74–75.
Oz, M.C., Rose, E.A. & Levin, H.R. (1995) Selection criteria for placement of left ventricular assist devices. American Heart Journal 129: 173–177.
Arabja, F.A., Smith, R.G., Jaffe, C., Wild, J.C., Rose, D.S., Nelson, R.J., McClellan, D.M., Acuna, G.A., Edling, N.G., Harrington, N.K., Rabago, G., Tsen, A.C., Arzouman, D.A., Sethi, G.K. & Copeland, J.G. (1996) Cost analysis of the Novacor left ventricular assist system as an outpatient bridge to heart transplantation. American Association for Artificial Internal Organs Journal 42: M546-M549.
Baxton, M. (1995) Economic evaluation of therapies for end-stage heart failure. In: Lewis, T., Graham, T.R., eds., Mechanical circulatory support. Edward Arnold Press, Boston: 344–362.
Harper, A.M. & Baker, A.S. (1995) The UNOS OPTN waiting list: 1988–1995. Clinical Transplantation 1: 69–84.
Author information
Authors and Affiliations
Additional information
This paper was written by the author while in the Masters degree progrm at Loma Linda University (Dept. of Biomedical and Clinical Ethics), 11234 Anderson Street, Coleman Pavillion, Loma Linda, CA 92354, USA.
The author is currently an Ethies Fellow (pre-doctoral) in UCLA’s program in Biomedical and Research Ethics.
Rights and permissions
About this article
Cite this article
Bramstedt, K.A. Left ventricular assist devices: An ethical analysis. SCI ENG ETHICS 5, 89–96 (1999). https://doi.org/10.1007/s11948-999-0060-3
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11948-999-0060-3